Source

Literatura:
Häuselmann HJ. Nutripharmaceuticals for osteoarthritis. Best Practice Res Clin Rheumatol 2001; 15(4):595-607
Sutton L, Rapport L, Lockwood B. Glucosamine: con or cure? Nutrition 2002; 18:534- 6.
Towheed, T., et al. Glucosamine for osteoarthritis. 2009 28.04.2015
Thakral R, Debnath UK, Det C. Role of glucosamine in osteoarthritis. Curr Orthopaed 2007; 21:386-9.
Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects considerations and efficacy. Food Chem Toxicol 2005; 43:187-201
Cibere J, Kopec JA, Thorne A i wsp. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthr Rheum 2004; 51(5):738-45.
Fransen M, Agaliotis M, Nairn M, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. 2015, 74(5):851-8.
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. British Medical Journal.2010;341
Fransen M, Agaliotis M, Nairn M, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. 2015, 74(5):851-8.  LEGS
Momomura R, et al.
Evaluation of the effect of glucosamine administration on biomarkers of cartilage and bone metabolism in bicycle racers
. Mol Med Report. 2013.